BioPharma Drug Discovery
RosVivo signed MTA for diabetes treatment with Eli Lilly and Company
RosVivo Therapeutics, Inc. (hereinafter referred to as "RosVivo") announced that it has signed a Material Transfer Agreement (MTA) with one of the largest ...
February 23, 2022 | News
CanSinoBIO's Convidecia™ Approved as Heterologous Booster in China
According to the State Council, for those aged 18 and above who have completed a 6-month vaccination schedule using inactivated COVID-19 vaccines, and thos...
February 21, 2022 | News
Quotient Sciences completes integration of drug substance into translational pharmaceutics® platform
Quotient Sciences – a global drug development and manufacturing accelerator offering a suite of services to clients in the pharmaceutical and bi...
February 18, 2022 | News
Lupin Signs Distribution Agreement with Medis for Orphan Drug NaMuscla®
Global pharma major, Lupin Limited (Lupin) announced today that it has entered into a distribution agreement with Medis for Lupin’s orphan drug NaMus...
February 11, 2022 | News
X-Chem and Excelra’s GOSTAR Join Forces to Advance Drug Discovery for Challenging Targets
Machine learning and artificial intelligence are reshaping discovery and optimization of drug candidates. This synergistic new partnership between Excelra&...
February 10, 2022 | News
Debiopharm and Aspen Partner to launch prostate cancer drug trelstar® in South Africa
In 2020, nearly 14,000 South African men were newly diagnosed with prostate cancer1 with an average of 5 men dying from the disease every day.2 I...
February 01, 2022 | News
I-Mab to Accelerate Commercialization of Innovative Biologics Drugs
This strategic partnership will accelerate I-Mab's commercialization strategy with an execution plan and timeline to commercialize its innovative assets, i...
January 31, 2022 | News
XtalPi Partners with Excelra for GOSTAR
Excelra, a leading global Data & Analytics organization, today announced the partnership for its Global Online Structure Activity Relationship Database...
January 19, 2022 | News
The Philippines Has Approved ReCOV For Phase II/III Clinical Trial
Recombinant Two-Component COVID-19 Vaccine (ReCOV) was approved for International Phase II/III Clinical Trial ReCOV induced high levels of neutralizing ...
January 18, 2022 | News
SANOFI to Advance ABL301 for the Treatment of Parkinson's Disease
ABL and SANOFI to collaborate on the development of ABL301, a potential first-in-class bispecific antibody targeting alpha-synuclein and containing a pro...
January 12, 2022 | News
CanSinoBIO Announces Approval for its MCV4 Product Menhycia™ in China
Leveraging CanSinoBIO's industry-leading synthetic biotechnology and formulation technology platform, Menhycia™ covalently binds common pathogen...
January 10, 2022 | News
Aurobindo rolls out molnaflu, oral covid drug for adult patients In India
Molnupiravir was earlier approved under Emergency Use Authorisation from CDSCO, India. This is the first oral antiviral approved by India, the UK agency an...
January 06, 2022 | News
SRI International Announces Collaboration Agreement with Janssen
SRI International (SRI) today announced the company has entered into a collaboration agreement with Janssen Pharmaceutica NV (Janssen), one of the Janssen ...
January 06, 2022 | News
Endo Launches First Generic Version of CUVPOSA® (glycopyrrolate) Oral Solution
"We're proud to provide families with a generic option of this important medication," said Jon Holden, Senior Vice President and General Manager, Gene...
January 05, 2022 | News
Most Read
- Lack of Regular Screening Fuels Rise in Late-Stage Breast Cancer in Hong Kong, New Report Reveals
- BIOCHINA 2025: Connecting Global Innovators with China's Leading Biotech Firms
- Leon Wyszkowski, President of Analytical Services, Discusses Thermo Fisher's Strategic Move: Expanding Bioanalytical Capabilities in Europe with New Sweden Lab
- The Role of Policy and Public Health Initiatives in Addressing Women's Cancer Care in Asia
- Redefining Patient Safety in the Age of Healthtech
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
Editor Picks
